Bridge to Life
Bridge to Life Ltd is a provider of organ preservation products and machine perfusion equipment focused on technologies and protocols to improve donor organ viability and transplant outcomes. The company supplies cold storage preservation solutions, perfusion consumables and hypothermic oxygenated machine perfusion systems, participates in multicenter clinical studies, curates clinical evidence, and organizes training and workshops for transplant professionals. It markets devices with CE marking outside the United States and has been preparing regulatory submissions for US market access.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Hypothermic oxygenated perfusion system
A clinical machine perfusion system designed to deliver oxygenated perfusate to donor organs at hypothermic temperatures to reduce metabolic demand and prime tissue prior to transplantation.
Cold storage preservation solution (UW formulation)
Organ preservation solution used for static cold storage during procurement and transport to maintain graft viability.
Slush preparation saline solution
Sodium chloride formulation intended for preparation of preservation slush used during organ procurement.
Perfusion cannulas and tubing (French-sized)
Cannulas and tubing sized for organ perfusion procedures compatible with machine perfusion setups.
Back Table Adaptor KP 16-32A
Back table adaptor designed for removal of perfusion fluid residues in organs.
25F Short-bent KP25-34-K-B
Short-bent French-sized cannula for organ perfusion.
Hypothermic oxygenated perfusion system
A clinical machine perfusion system designed to deliver oxygenated perfusate to donor organs at hypothermic temperatures to reduce metabolic demand and prime tissue prior to transplantation.
Cold storage preservation solution (UW formulation)
Organ preservation solution used for static cold storage during procurement and transport to maintain graft viability.
Slush preparation saline solution
Sodium chloride formulation intended for preparation of preservation slush used during organ procurement.
Perfusion cannulas and tubing (French-sized)
Cannulas and tubing sized for organ perfusion procedures compatible with machine perfusion setups.
Back Table Adaptor KP 16-32A
Back table adaptor designed for removal of perfusion fluid residues in organs.
25F Short-bent KP25-34-K-B
Short-bent French-sized cannula for organ perfusion.
Services
Support for multicenter clinical studies and investigator-led research evaluating machine perfusion and preservation methods.
Hands-on workshops, symposia and webinars to train clinicians in machine perfusion techniques and protocol adoption.
Curation and dissemination of peer-reviewed publications, clinical data and guidance materials related to organ perfusion and preservation.
Support for multicenter clinical studies and investigator-led research evaluating machine perfusion and preservation methods.
Hands-on workshops, symposia and webinars to train clinicians in machine perfusion techniques and protocol adoption.
Curation and dissemination of peer-reviewed publications, clinical data and guidance materials related to organ perfusion and preservation.
Expertise Areas
- Organ preservation and perfusion
- Machine perfusion system commercialization
- Transplant clinical trial management
- Viability biomarker evaluation for graft assessment
Key Technologies
- Hypothermic oxygenated perfusion (HOPE)
- Hypothermic machine perfusion systems
- Static cold storage solutions (UW formulation)
- Perfusate solutions and oxygenation systems
News & Updates
Announcement of accepted abstracts and a sponsored symposium on hypothermic oxygenated perfusion at the 2025 International Congress of the International Liver Transplantation Society (ILTS).
Acquisition of a hypothermic oxygenated machine perfusion system and associated global rights from an external MedTech supplier to expand product portfolio.
Hosted and published a recorded Knowledge Hub discussion and related educational material on treatment and assessment of liver grafts during hypothermic oxygenated perfusion.
Company CEO discusses normothermic regional perfusion, HOPE, and the potential synergy of combining in situ recovery with end‑ischemic oxygenated perfusion to improve organ utilization.
Summary of three Italian clinical studies presented at TTS 2024 on safety and biomarker identification using hypothermic oxygenated perfusion in liver transplantation.
Reported milestone of over 5,000 liver perfusions performed worldwide using hypothermic oxygenated perfusion in combination with the company's machine perfusion system (based on perfusion set sales through Oct 31, 2024).
Announcement of accepted abstracts and a sponsored symposium on hypothermic oxygenated perfusion at the 2025 International Congress of the International Liver Transplantation Society (ILTS).
Acquisition of a hypothermic oxygenated machine perfusion system and associated global rights from an external MedTech supplier to expand product portfolio.
Hosted and published a recorded Knowledge Hub discussion and related educational material on treatment and assessment of liver grafts during hypothermic oxygenated perfusion.
Company CEO discusses normothermic regional perfusion, HOPE, and the potential synergy of combining in situ recovery with end‑ischemic oxygenated perfusion to improve organ utilization.
Summary of three Italian clinical studies presented at TTS 2024 on safety and biomarker identification using hypothermic oxygenated perfusion in liver transplantation.
Reported milestone of over 5,000 liver perfusions performed worldwide using hypothermic oxygenated perfusion in combination with the company's machine perfusion system (based on perfusion set sales through Oct 31, 2024).